Results 231 to 240 of about 8,135,374 (287)
British Journal of Clinical Pharmacology, EarlyView.Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez +2 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Empirical Analysis of the Incidence of Employer's Contributions for Health Care and Long Term Care Insurances in Japan [PDF]
Miyazato, Naomi, Ogura, Seiritsu
core
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao +3 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Social Insurances and Risky Financial Market Participation: Evidence from China
Emerging markets finance & trade, 2022Using four-wave national longitudinal survey data, this study estimates the influence of pension and medical insurance on risky financial market participation for individuals aged ≥ 45 years in China. Three key findings emerge.
Xinxin Ma
semanticscholar +1 more source
Health Insurances and the Health-Related Work Capacity of Retirement-Aged Workers
Journal of Occupational and Environmental Medicine, 2021Systematic inequity across different health insurances can bring risk to retirement-aged workers and lead to their contrasting health outcomes. Policymakers need more fine-grained design of health insurances to better protect retirement-aged workers ...
Jiannan Li, B. Yuan
semanticscholar +1 more source
Social Insurance for the Elderly
SSRN Electronic Journal, 2020Abstract We study the effects of retirement benefits provided by social insurance programs on consumption, portfolio choice, and retirement in a continuous-time theoretical model. We show that people tend to retire earlier with an increase in retirement social insurance benefits (SIBs), consistent with empirical evidence.
Se Yung Bae +3 more
openaire +1 more source
How Does COVID-19 Affect China’s Insurance Market?
, 2020The insurance market has been greatly impacted by the outbreak of the COVID-19 pandemic. We employ monthly provincial panel data and fixed-effects models to study how COVID-19 has impacted China’s insurance market.
Yating Wang +3 more
semanticscholar +1 more source